MKM downgrades Pfizer; "Neutral" Rating (PFE)

MKM downgrades Pfizer; “Neutral” Rating (PFE)


MKM Partners reported on Tuesday that they have downgraded global biopharmaceutical company, Pfizer Inc.(PFE).

The firm announced that they have downgraded the company from a “Buy” to “Neutral.” Analysts believe that PFE has few near-term catalysts and a weak pipeline.

Pfizer shares were mostly flat during premarket trading Tuesday. The stock is up 13.17% YTD.

The Bottom Line
Shares of Pfizer (PFE) have a 3.59% dividend yield, based on last night’s closing stock price of $24.49. We have been recommending shares of Pfizer (PFE) since Mar.2, 2012, when the stock was trading at $21.49.

Pfizer Inc.(PFE) is a “Recommended” dividend stock at this time, holding a DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today